The correlation between breast cancer and Parkinson's disease: a meta-analysis
Cun Liu,Lu Wang,Jinhui Tian,Lijuan Liu,Linxiang Guo,Guowen Ge,Liang Zheng,Fubin Feng,Jinmei Zhang,Tingting Zhang,Changgang Sun
DOI: https://doi.org/10.18632/oncotarget.24199
2015-01-01
Oncotarget
Abstract:// Cun Liu 1, * , Lu Wang 1, * , Jinhui Tian 2 , Lijuan Liu 3 , Linxiang Guo 4 , Guowen Ge 5 , Liang Zheng 6 , Fubin Feng 3 , Jinmei Zhang 7 , Tingting Zhang 1 and Changgang Sun 3, 8 1 College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250014, Shandong, PR China 2 Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou 730000, Gansu, PR China 3 Department of Oncology, Weifang Traditional Chinese Hospital, Weifang 261041, Shandong Province, PR China 4 School of Foreign Language Education, Qingdao University, Qingdao 266071, Shandong, PR China 5 Clinical College, Weifang Medical University, Weifang 261000, Shandong, PR China 6 Department of Cardiovascular Medicine, Research Center for Translational Medicine, Dongfang Hospital, Tongji University, Shanghai 200000, PR China 7 Department of Endocrinology, Weifang Traditional Chinese Hospital, Weifang 261041, Shandong, PR China 8 Department of Oncology, Affiliated Hospital of Weifang Medical University, Weifang 261031, Shandong, PR China * These authors contributed equally to this work and are co-first authors Correspondence to: Changgang Sun, email: zhongliuyike@163.com Keywords: breast cancer; Parkinsonu0027s disease; meta-analysis; risk Received: October 11, 2017 Accepted: December 05, 2017 Published: January 02, 2018 ABSTRACT Objective: We performed a meta-analysis to explore the association between breast cancer and Parkinson’s disease (PD). Materials and Methods: Specific literature searches were performed systematically using PubMed, Cochrane Library and EMBASE. Studies about the related risk estimates of breast cancer and PD were included in the meta-analysis. Results: A total of 22 sets of research data from 16 studies were analyzed. The combined odds ratio (OR) of the results was 1.13 (95% CI: 1.09–1.17). When stratified by PD diagnosis time, the ORs for the occurrence of breast cancer before and after PD diagnosis were 0.99 (95% CI: 0.89–1.09) and 1.15 (95% CI: 1.10–1.20). Subgroup analysis showed that the ORs for the cohort studies and for Caucasians were 1.13 (95% CI: 1.09,1.08) and 1.13 (95% CI: 1.09–1.17), respectively. No statistically significant risk estimates were found for studies in Asian and mixed populations as well as for case-control studies ( P u003e 0.05). Conclusions: The current evidence demonstrates a positive correlation between breast cancer and PD, especially following a diagnosis of PD and in Caucasians. Further studies are needed to determine the pathophysiologic mechanisms of this relationship.